Is the USA on track to end the HIV epidemic?

Vincent Guilamo-Ramos; Marco Thimm-Kaiser; Adam Benzekri

doi:10.1016/S2352-3018(23)00142-X

Is the USA on track to end the HIV epidemic?

Lancet HIV. 2023 Aug;10(8):e552-e556. doi: 10.1016/S2352-3018(23)00142-X.

Authors

Vincent Guilamo-Ramos¹, Marco Thimm-Kaiser², Adam Benzekri²

Affiliations

¹ Center for Latino Adolescent and Family Health and School of Nursing, Duke University, Durham, NC, USA; Department of Family Medicine and Community Health and Department of Infectious Diseases, School of Medicine, Duke University, Durham, NC, USA; Presidential Advisory Council on HIV/AIDS, US Department of Health and Human Services, Washington, DC, USA; CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, US Department of Health and Human Services, Atlanta, GA, USA; Panel on Antiretroviral Guidelines for Adults and Adolescents, Office of AIDS Research Advisory Council, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA. Electronic address: vincent.ramos@duke.edu.
² Center for Latino Adolescent and Family Health and School of Nursing, Duke University, Durham, NC, USA.

PMID: 37541707
DOI: 10.1016/S2352-3018(23)00142-X

Abstract

Despite progress in reducing new HIV infections in the USA, publicly available data suggest that new HIV infections continue to occur at an alarming rate. In this Viewpoint, we highlight the regularity with which the existing systems for HIV prevention and treatment delivery in the USA fail and the clearly inequitable effect of the systems' failure among several priority populations of the Ending the HIV Epidemic (EHE) initiative. Existing data cast doubt on whether the current EHE efforts will suffice to achieve its 2030 goal of reducing annual new HIV infections to fewer than 3000. We outline future directions in four priority areas to regain lost ground in pursuit of the 2030 EHE goals: reducing the stigma affecting people living with and most at risk of HIV; broadening the HIV workforce; mitigating harmful social determinants of health; and recommitting and reinvesting in health in the USA more broadly.

Publication types

Review

MeSH terms

Acquired Immunodeficiency Syndrome* / epidemiology
Epidemics* / prevention & control
Forecasting
HIV Infections* / drug therapy
HIV Infections* / epidemiology
HIV Infections* / prevention & control
Humans